Envoy Medical Inc. logo

Envoy Medical Inc.

COCH | NASDAQ
Chart Builder DCF Calculator
$0.72
+$0.01 (+1.34%)
Sep 22, 2026, 2:42 PM ET · Market open

Market Data

Market Cap
$14.78M
Enterprise Value
$-4.09M
Beta
1.90
Average Volume
299.67K
Shares Outstanding (Diluted)
104.04M
Shares Change YoY
430.81%
Institutional Ownership
25.08%
Exchange
NASDAQ
ISIN
US29415V1098

Price Performance

Price Change 1M
-5.3%
Price Change 3M
9.2%
Price Change 6M
3.8%
Price Change YTD
2.1%
Price Change 1Y
-24.8%
Price Change 3Y
-93.2%
Price Change 5Y
-92.7%
1M CAGR (ann.)
5.9%
1Y CAGR (ann.)
-48.1%
5Y CAGR (ann.)
-40.8%
All-Time CAGR
-38.4%

Valuation

PE Ratio
-1.06
Forward PE
N/A
PEG Ratio
-0.01
Forward PEG
0.04
PS Ratio
71.39
Forward PS
147.80
PB Ratio
4.47
P/FCF Ratio
-0.68
P/Adj. FCF Ratio
-0.66
P/OCF Ratio
-3.38
EV/Sales
-19.76
EV/EBIT
0.18
EV/EBITDA
0.18
EV/FCF
0.19
Earnings Yield
-94.4%
FCF Yield
-146.9%
Adj. FCF Yield
-150.9%

Financial Health

Net Cash
$19.68M
Total Debt
$810K
Cash & Short-Term Investments
$19.68M
Total Assets
$23.95M
Current Ratio
1.73
Quick Ratio
1.61
Debt / Equity Ratio
0.25
Debt / EBITDA
-0.04
Debt / FCF
-0.04
OCF / Debt
-26.58
Interest Coverage
-50.15
Altman Z-Score
-21.34
Piotroski F-Score
4

Margins & Profitability

Gross Profit Margin
-385.5%
Operating Profit Margin
-11411.1%
EBITDA Margin
-10567.6%
Net Profit Margin
-11304.8%
FCF Margin
-10488.4%
Adj. FCF Margin
-10775.4%
SBC / Revenue
287.0%
SBC Impact (per share)
-2.7%

Returns

Return on Assets
-97.7%
Return on Equity
1719.7%
Return on Invested Capital
-206.3%
Return on Capital Employed
-208.8%
Return on Tangible Assets
-97.7%

Historical Growth (CAGR)

Revenue CAGR 3Y
-1.7%
Revenue CAGR 5Y
4.4%
Revenue CAGR 10Y
N/A
EPS CAGR 3Y
9.9%
EPS CAGR 5Y
0.0%
EPS CAGR 10Y
N/A
FCF CAGR 3Y
-0.5%
FCF CAGR 5Y
-22.5%
FCF CAGR 10Y
N/A

Analyst Forecasts

Analyst Rating
Buy
Analyst Count
3
EPS Growth Next 3Y
N/A
Revenue Growth Next 3Y
658.7%
Earnings Date
Nov 8, 2026
EPS Estimate (next Q)
-$0.07
EPS Growth Est (next Q)
-80.0%
Revenue Est (next Q)
$50K
Revenue Growth Est (next Q)
19.1%

Fair Value Estimates

Graham Number
N/A
Graham Upside
N/A
Lynch Fair Value
N/A
Lynch Upside
N/A
Price Target
$2
Price Target Upside
181.7%

Cash Flow

Operating Cash Flow
$-21.53M
Free Cash Flow
$-21.71M
Adj. Free Cash Flow
$-22.31M
FCF Per Share
-$0.21
OCF Per Share
-$0.21
OCF/S Ratio
-10402.4%

Income Statement

Revenue
$207K
Gross Profit
$-798K
Operating Income
$-23.62M
EBITDA
$-22.63M
Net Income
$-23.4M
EPS (Diluted)
-$0.67
Revenue / Employee
$4.81K
Profit / Employee
$-544.21K
Employees
43

© 2026 bestshares.com. All rights reserved.